Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02690168 · ClinicalTrials.gov registry record
Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 6
- Enrollment target
NCT02690168 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 6 participants.
The verdict
NCT02690168 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Hypoglycemia-associated autonomic failure (HAAF), a condition commonly developed in diabetic patients, which causes them to have severely low blood sugar levels. This condition makes clinical management of blood sugar in diabetic patients very challenging. This research seeks to better understand how diabetic patients develop HAAF, and what can be done to prevent it.
Interventions
- BEHAVIORAL Fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02690168
The ClinicalTrials.gov registry entry for NCT02690168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fasting is the first listed.
NCT02690168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02690168 about?
NCT02690168 is a clinical study titled "Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy". Hypoglycemia-associated autonomic failure (HAAF), a condition commonly developed in diabetic patients, which causes them to have severely low blood sugar levels. This condition makes clinical management of blood sugar in diabetic patients very challenging. This research seeks to better understand ho...
What is the current status of trial NCT02690168?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2016-02. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02690168?
The interventions under investigation include: Fasting (BEHAVIORAL).
Who is sponsoring clinical trial NCT02690168?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.